Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
出版年份 2020 全文链接
标题
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
作者
关键词
Osteosarcoma, Cancer immunotherapy, PD-1, PD-L1, Tumor immune microenvironment
出版物
CANCER LETTERS
Volume 500, Issue -, Pages 1-10
出版商
Elsevier BV
发表日期
2020-12-23
DOI
10.1016/j.canlet.2020.12.024
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma
- (2020) Zhuochao Liu et al. Aging-US
- Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells
- (2020) Kazushige Yoshida et al. BMC CANCER
- Bone sarcomas in the immunotherapy era
- (2020) Marie‐Françoise Heymann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
- (2020) Zhidong Wang et al. Frontiers in Immunology
- Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+conventional dendritic cells
- (2020) Yifan Zhou et al. Journal for ImmunoTherapy of Cancer
- Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity
- (2020) Su-Nam Jeong et al. Cancers
- Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
- (2020) Jun Wang et al. JOURNAL OF NANOBIOTECHNOLOGY
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Current and Emerging Targets in Immunotherapy for Osteosarcoma
- (2019) Shinji Miwa et al. Journal of Oncology
- Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways
- (2019) Tingting Ren et al. Cell Death & Disease
- Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
- (2019) Suchismita Mohanty et al. Cell Death & Disease
- Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
- (2019) Elizabeth R Butch et al. CANCER RESEARCH
- miR‐134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP 1 and MMP 3 in vitro and in vivo
- (2019) Cheng‐long Chen et al. FEBS LETTERS
- Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
- (2019) Yitian Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis
- (2019) Chenglong Chen et al. Clinical Genitourinary Cancer
- Emerging trends in immunotherapy for pediatric sarcomas
- (2019) Kyle A. Dyson et al. Journal of Hematology & Oncology
- Advances in immune checkpoint inhibitors for bone sarcoma therapy
- (2019) Pichaya Thanindratarn et al. Journal of Bone Oncology
- Tumour-Derived Extracellular Vesicles (EVs): A Dangerous “Message in A Bottle” for Bone
- (2019) Alfredo Cappariello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma
- (2019) Naoki Mizoshiri et al. CELLULAR ONCOLOGY
- Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
- (2019) Jingzhe Zhang et al. Journal of Bone Oncology
- SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy
- (2019) Kuo Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3
- (2018) Bingxin Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1
- (2018) Hongsheng Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
- (2018) Binghao Li et al. CANCER RESEARCH
- PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
- (2018) Bingxin Zheng et al. Journal of Hematology & Oncology
- Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma
- (2018) Lan Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- Immunotherapy for osteosarcoma: Where do we go from here?
- (2018) Mary F. Wedekind et al. PEDIATRIC BLOOD & CANCER
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
- (2018) Pooja Dhupkar et al. Cancer Medicine
- Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
- (2018) Zhan Wang et al. Frontiers in Immunology
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis
- (2018) Yu Han et al. CANCER LETTERS
- Macrophage-derived IL-1β and TNF-α regulate arginine metabolism in neuroblastoma
- (2018) Livingstone Fultang et al. CANCER RESEARCH
- Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma
- (2018) Brian H. Kushner et al. JAMA Oncology
- Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy
- (2018) Wei Yu et al. BIOMATERIALS
- Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells
- (2017) Ryan M. Troyer et al. EXPERIMENTAL CELL RESEARCH
- Current and future therapeutic approaches for osteosarcoma
- (2017) Douglas J. Harrison et al. Expert Review of Anticancer Therapy
- Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
- (2017) Cristina Meazza et al. MEDICAL ONCOLOGY
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
- (2017) Lars Wagner et al. OncoTargets and Therapy
- Cancer associated fibroblasts: An essential role in the tumor microenvironment
- (2017) Leilei Tao et al. Oncology Letters
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
- (2017) Qian Zhou et al. Cancer Immunology Research
- Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
- (2017) Simin Kiany et al. OncoImmunology
- Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies
- (2016) Chuang Sun et al. BLOOD
- Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
- (2016) N. J. Mason et al. CLINICAL CANCER RESEARCH
- Progress and opportunities for immune therapeutics in osteosarcoma
- (2016) Christina K Lettieri et al. Immunotherapy
- T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
- (2016) Aude G. Chapuis et al. JOURNAL OF CLINICAL ONCOLOGY
- The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma
- (2016) Ling Wang et al. TUMOR BIOLOGY
- Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma
- (2016) MASANORI KAWANO et al. Oncology Letters
- T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
- (2016) Zhan Wang et al. Frontiers in Immunology
- TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
- (2016) Audrey Lamora et al. Journal of Clinical Medicine
- Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
- (2016) Pratistha Koirala et al. Scientific Reports
- Bone microenvironment signals in osteosarcoma development
- (2015) Arantzazu Alfranca et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Immunotherapeutic Approaches to Sarcoma
- (2015) Melissa Burgess et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Expression of B7-H3 in cancer tissue during osteosarcoma progression in nude mice
- (2015) S.J. Yin et al. GENETICS AND MOLECULAR RESEARCH
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccinia Virus B1 Kinase Is Required for Postreplicative Stages of the Viral Life Cycle in a BAF-Independent Manner in U2OS Cells
- (2015) Augusta Jamin et al. JOURNAL OF VIROLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
- (2015) C Krupka et al. LEUKEMIA
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma
- (2015) MASANORI KAWANO et al. ONCOLOGY REPORTS
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Exosomes and their roles in immune regulation and cancer
- (2015) David W. Greening et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
- (2015) Ji-Feng Xu et al. Oncotarget
- Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- (2015) Danielle M Lussier et al. Journal for ImmunoTherapy of Cancer
- Increased CTLA-4+ T cells and an increased ratio of monocytes with loss of class II (CD14+ HLA-DRlo/neg) found in aggressive pediatric sarcoma patients
- (2015) Pooja Hingorani et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy of Childhood Sarcomas
- (2015) Stephen S. Roberts et al. Frontiers in Oncology
- Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma
- (2015) Binghao Li et al. Oncotarget
- Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors
- (2014) J. Fu et al. CANCER RESEARCH
- Comprehensive Evaluation of the Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphisms in Risk of Bone Sarcoma
- (2014) Shouying Liu et al. Genetic Testing and Molecular Biomarkers
- Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment
- (2014) Aude I. Ségaliny et al. INTERNATIONAL JOURNAL OF CANCER
- Going back to class I: MHC and immunotherapies for childhood cancer
- (2014) Kellie B. Haworth et al. PEDIATRIC BLOOD & CANCER
- Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8+ T Cells: Mechanism of Immune Evasion
- (2014) Marie Lundholm et al. PLoS One
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
- (2014) M. T. Isla Larrain et al. TUMOR BIOLOGY
- Programmed Cell Death Ligand 1 Expression in Osteosarcoma
- (2014) J. K. Shen et al. Cancer Immunology Research
- T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing
- (2013) K. Kudo et al. CANCER RESEARCH
- Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma
- (2013) MASANORI KAWANO et al. ONCOLOGY REPORTS
- Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis
- (2013) Sergei R. Guma et al. PEDIATRIC BLOOD & CANCER
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors
- (2013) Fengbin Yu et al. TUMOR BIOLOGY
- Effect of the cytokine levels in serum on osteosarcoma
- (2013) Hong Xiao et al. TUMOR BIOLOGY
- Anti-TGF-β Antibody Combined with Dendritic Cells Produce Antitumor Effects in Osteosarcoma
- (2012) Masanori Kawano et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma
- (2012) BEN-GEN ZHOU et al. ONCOLOGY REPORTS
- Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
- (2011) N Rainusso et al. CANCER GENE THERAPY
- Genetically Modified T cells Targeting Interleukin-11 Receptor -Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases
- (2011) G. Huang et al. CANCER RESEARCH
- Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
- (2011) E. P. Buddingh et al. CLINICAL CANCER RESEARCH
- Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity
- (2011) Sophie R. Sierro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway
- (2011) Zhaoxu Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
- (2010) J. Dong et al. MOLECULAR CANCER THERAPEUTICS
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Caspase-6 and Anti-HER2 Antibody Chimeric Tumor-Targeted Proapoptotic Molecule Decreased Metastasis of Human Osteosarcoma
- (2009) Li-Feng Wang et al. CANCER INVESTIGATION
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- Immunotherapy with Interleukin-18 in Combination with Preoperative Chemotherapy with Ifosfamide Effectively Inhibits Postoperative Progression of Pulmonary Metastases in a Mouse Osteosarcoma Model
- (2009) Naoko Yamada et al. TUMOR BIOLOGY
- A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
- (2008) C. L. Mackall et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now